Boston Scientific diskutieren
Boston Scientific
WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /
78,40 €
-0,25 %
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Leerink Partners from $127.00 to $128.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Robert W. Baird from $123.00 to $128.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at BTIG Research from $127.00 to $132.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $121.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Truist Financial Corporation from $125.00 to $129.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Barclays PLC from $133.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $121.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $132.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Wells Fargo & Company from $124.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) was given a new $130.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its price target raised by analysts at Truist Financial Corporation from $129.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $132.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for BSX provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Progressive Corp. diskutieren